In This Democratic Debate, Health Care Issues Took A Back Seat
The latest Democratic debate did not dwell on “Medicare for All,” despite strong divisions among the presidential candidates.
Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
Health Care Stayed Front And Center At Democratic Debate
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
Think ‘Medicare For All’ Is The Only Democratic Health Plan? Think Again
The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates’ ideas on many other issues, such as mental health and gun safety, have attracted much less attention.
Hill Hodgepodge: Pelosi Draws From Democrats, GOP And Trump For Drug Plan
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Do 50 Million People Really Lose Health Coverage Each Year Because Of Their Jobs?
Sen Bernie Sanders’ statement during Thursday night’s Democratic debate serves up interesting data, with a side of misrepresentation.
Despite Repeated Calls For Unity, Democrats Throw Debate Punches On Health Plans
When it came to health care plans, there were big ideas and big numbers, even though fewer candidates were on the stage.
Legislation To End Surprise Medical Bills Has High Public Support — In Both Parties
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
Investors’ Deep-Pocket Push To Defend Surprise Medical Bills
As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.
Pharma Cash Rolls Into Congress To Defend An Embattled Industry
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.